Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382915 · ClinicalTrials.gov registry record
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
A clinical trial, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 276
- Enrollment target
NCT00382915 is a clinical trial that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 276 participants.
The verdict
NCT00382915 has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
This study will evaluate the differences in smoking behavior, nicotine intake, and nicotine boost among people with schizophrenia, bipolar disorder, or no mental illness.
Interventions
- DEVICE CReSSmicro handheld topography device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382915
The ClinicalTrials.gov registry entry for NCT00382915 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CReSSmicro handheld topography device is the first listed.
NCT00382915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382915 about?
NCT00382915 is a clinical study titled "Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder". This study will evaluate the differences in smoking behavior, nicotine intake, and nicotine boost among people with schizophrenia, bipolar disorder, or no mental illness.
What is the current status of trial NCT00382915?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2006-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00382915?
The interventions under investigation include: CReSSmicro handheld topography device (DEVICE).
Who is sponsoring clinical trial NCT00382915?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.